Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503877 · ClinicalTrials.gov registry record · NA
Media, Morphokinetics, and Mosaicism
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT03503877 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 200 participants.
The verdict
NCT03503877, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Embryonic aneuploidy is the underlying etiology for the majority of failed implantation and miscarriage. Preimplantation genetic screening (PGS) with transfer of a euploid embryo has been advocated as a strategy for increasing live birth rates with a single embryo transfer. Culturing embryos to the blastocyst stage for trophectoderm biopsy is a requirement for PGS. Several commercially-available single-step embryonic culture media with varying composition have been established for use in the IVF laboratory. Early reports have suggested differences in clinical outcomes, such as aneuploidy and miscarriage rates, with distinct culture media currently in standard use. However, there have been no clinical trials demonstrating the superiority of any one commercially-available culture media formulation. As a result, clinics use media with varying composition based upon familiarity and cost.
Interventions
- DEVICE EmbryoScope Plus
- OTHER GLOBAL MEDIA
- OTHER SAGE MEDIA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-02-14 |
| Est. Completion | 2019-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03503877
The ClinicalTrials.gov registry entry for NCT03503877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which EmbryoScope Plus is the first listed.
NCT03503877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03503877 about?
NCT03503877 is a clinical study titled "Media, Morphokinetics, and Mosaicism". Embryonic aneuploidy is the underlying etiology for the majority of failed implantation and miscarriage. Preimplantation genetic screening (PGS) with transfer of a euploid embryo has been advocated as a strategy for increasing live birth rates with a single embryo transfer. Culturing embryos to the ...
What is the current status of trial NCT03503877?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2018-02-14. Estimated completion is 2019-11-28.
What interventions are being tested in trial NCT03503877?
The interventions under investigation include: EmbryoScope Plus (DEVICE), GLOBAL MEDIA (OTHER), SAGE MEDIA (OTHER).
Who is sponsoring clinical trial NCT03503877?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.